Browse studies

Find your next paid study

1 recruiting study matching your filters

A Double-blind, Randomized, Placebo-controlled Phase 2 Study to Evaluate Efficacy and Safety of Kylo-11 in Participants With Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a)

This is a phase 2, double-blind, randomized, placebo-controlled, multi-center, dose-finding study to evaluate the efficacy and safety of Kylo-11 administered s…

Lipoprotein Disorder

Estimated

~$10 – $8,750

Kylonova (Xiamen) Biopharma co., LTD.NCT07327840